Integra LifeSciences | IART - PE价格收益



金融业
股票价格
USD
资产
USD 3.56B
现金及等价物
USD 214.42M
销售成本
USD 188.86M
流动资产
USD 1.19B
流动负债
USD 330.88M
债务
USD 2.04B
EBIT
USD 41.29M
EBITDA
USD 78.41M
员工
4.4K
EPS每股收益
USD 0.56
股本和储备
USD 1.04B
销售毛利
USD 215.97M
债务利息支出
USD 22.99M
利息收入
USD 4.11M
贷款资金
USD 1.83B
市值
USD 1.31B
净收入
USD 4.48M
营业费用
USD 1.04B
营业利润
USD 41.29M
普通股股本
USD 77.78M
PE价格收益
10.28
税前利润
USD -2.41M
销售收入
USD 418.8M
销售和管理费用
USD 166.22M
股票
USD 492.01M
贸易债权人
USD 82.64M
应收帐款人
USD 267.19M


Pe 更改 日
Abbott 23.85 1.08 2026-06
AtriCure 129.01 94.86 2026-06
Baxter International 151.95 65.95 2026-06
Becton, Dickinson and Co. 16.04 9.65 2026-06
Boston Scientific 17.86 14.49 2026-06
CONMED 9.39 17.48 2026-03
Cooper Companies 23.27 16.99 2026-03
Dexcom 24.61 0.12 2026-06
Edwards Lifesciences 30.77 3.9 2026-06
Globus Medical 22.31 12.99 2026-06
Insulet 29.66 9.17 2026-06
Integra LifeSciences 10.28 5.21 2026-06
Intuitive Surgical 44.59 11.23 2026-06
J&J 29.43 4.9 2026-06
Medtronic 19.66 3.1 2026-03
Merit Medical Systems 32.36 12.84 2026-03
Orthofix International 4.17K 3.83K 2021-06
Smith & Nephew 13.76 3.86 2026-06
Stryker 27.46 2.98 2026-06
Tandem Diabetes Care 681.05 189.32 2022-03
Teleflex 89.77 40.52 2026-06
Zimmer Biomet Holdings 17.33 8.14 2026-06